Sonendo, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SONX research report →
Companysonendo.com
Sonendo, Inc. , a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure.
- CEO
- Bjarne Bergheim
- IPO
- 2021
- Employees
- 129
- HQ
- Laguna Hills, CA, US
Price Chart
Valuation
- Market Cap
- $260.71K
- P/E
- -1.03
- P/S
- 0.01
- P/B
- 5.58
- EV/EBITDA
- -0.34
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 37.35%
- Op Margin
- -92.63%
- Net Margin
- -88.43%
- ROE
- -166.81%
- ROIC
- -120.65%
Growth & Income
- Revenue
- $31.70M · -27.73%
- Net Income
- $-28,033,000 · 53.98%
- EPS
- $-0.59 · 9.23%
- Op Income
- $-29,366,000
- FCF YoY
- 47.20%
Performance & Tape
- 52W High
- $1.52
- 52W Low
- $0.02
- 50D MA
- $0.41
- 200D MA
- $0.25
- Beta
- 2.20
- Avg Volume
- 466
Get TickerSpark's AI analysis on SONX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 17, 24 | McGaugh John P. | other | 500,000 |
| Sep 17, 24 | Bostjancic John J. | other | 600,000 |
| Sep 17, 24 | Bergheim Bjarne | other | 1,600,000 |
| Sep 17, 24 | Pudipeddi Vamsi Mohan Raj | other | 200,000 |
| Sep 17, 24 | BEAVER CAROLYN | other | 200,000 |
| Sep 17, 24 | Bihl Anthony P III | other | 200,000 |
| Sep 17, 24 | BERGHEIM OLAV | other | 200,000 |
| Jun 20, 24 | Chen Roy T | sell | 8,510 |
| Jun 21, 24 | Bergheim Bjarne | sell | 43,240 |
| Jun 5, 24 | Bostjancic John J. | other | 720,000 |
Our SONX Coverage
We haven't published any research on SONX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SONX Report →